November Private Market UpdatePrivate market metrics show signs of optimism despite October public market slump
November Private Market Update
Trading
Data
Solutions
Insights
About
Tessera Therapeutics was founded in 2018 by Jake Rubens and Geoffrey von Maltzahn. The company has not publicly endorsed plans to participate in an IPO.
Tessera is a biotech company developing gene editing technology to fight disease. The company has raised more than $500 million in venture capital funding from investors including SoftBank Vision Fund 2, T. Rowe Price Associates, Altitude Life Science Ventures, ARTIS Ventures, Cormorant Asset Management, and the Abu Dhabi Investment Authority. The company did not disclose valuation figures following a $300 million Series C fundraising round in 2022.
These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO.
Tessera does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.
The stock price for Tessera will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).
| Date | Funding Round | Funding Raised | Price per Share | Last Known Valuation |
|---|---|---|---|---|
| 4/19/2022 | Series C | $300MM raised | $XXX.XX | $XXX.XX |
| 1/12/2021 | Series B | $232.5MM raised | $XXX.XX | $XXX.XX |
| 7/7/2020 | Series A, A-1 and A-2 | $26.41MM raised | $XXX.XX | $XXX.XX |
Tessera is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
If you own Tessera pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.
Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.
Tessera is a private company and not publicly traded.
If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.
